213 related articles for article (PubMed ID: 15466256)
1. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family.
Hudson BG
J Am Soc Nephrol; 2004 Oct; 15(10):2514-27. PubMed ID: 15466256
[No Abstract] [Full Text] [Related]
2. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
[TBL] [Abstract][Full Text] [Related]
3. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
4. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
5. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
6. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
7. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
Cosgrove D; Liu S
Matrix Biol; 2017 Jan; 57-58():45-54. PubMed ID: 27576055
[TBL] [Abstract][Full Text] [Related]
8. Complex genetics of Alport and Goodpasture syndromes.
Tryggvason K
Nat Rev Nephrol; 2021 Oct; 17(10):635-636. PubMed ID: 34140670
[No Abstract] [Full Text] [Related]
9. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis.
Hudson BG; Reeders ST; Tryggvason K
J Biol Chem; 1993 Dec; 268(35):26033-6. PubMed ID: 8253711
[No Abstract] [Full Text] [Related]
10. Pathology of glomerular basement membrane nephropathy.
Hudson BG; Kalluri R; Tryggvason K
Curr Opin Nephrol Hypertens; 1994 May; 3(3):334-9. PubMed ID: 7922261
[TBL] [Abstract][Full Text] [Related]
11. Goodpasture's disease--new secrets revealed.
Salant DJ
N Engl J Med; 2010 Jul; 363(4):388-91. PubMed ID: 20660408
[No Abstract] [Full Text] [Related]
12. Collagen IV
Pokidysheva EN; Seeger H; Pedchenko V; Chetyrkin S; Bergmann C; Abrahamson D; Cui ZW; Delpire E; Fervenza FC; Fidler AL; Fogo AB; Gaspert A; Grohmann M; Gross O; Haddad G; Harris RC; Kashtan C; Kitching AR; Lorenzen JM; McAdoo S; Pusey CD; Segelmark M; Simmons A; Voziyan PA; Wagner T; Wüthrich RP; Zhao MH; Boudko SP; Kistler AD; Hudson BG
J Biol Chem; 2021; 296():100590. PubMed ID: 33774048
[TBL] [Abstract][Full Text] [Related]
13. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
[TBL] [Abstract][Full Text] [Related]
14. The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain.
Kang JS; Kashtan CE; Turner AN; Heidet L; Hudson BG; Borza DB
J Biol Chem; 2007 Apr; 282(14):10670-7. PubMed ID: 17293596
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of glomerular type IV collagen alpha3-5 chain expression in children with thin basement membrane disease.
Ueda T; Nakajima M; Akazawa H; Maruhashi Y; Shimoyama H; Sakagami Y; Takagawa K; Kamitsuji H; Naito I; Sado Y; Yoshioka A
Nephron; 2002 Oct; 92(2):271-8. PubMed ID: 12218303
[TBL] [Abstract][Full Text] [Related]
16. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
17. Regulation of collagen type IV genes is organ-specific: evidence from a canine model of Alport syndrome.
Zheng K; Perry J; Harvey SJ; Sado Y; Ninomiya Y; Jefferson B; Jacobs R; Hudson BG; Thorner PS
Kidney Int; 2005 Nov; 68(5):2121-30. PubMed ID: 16221211
[TBL] [Abstract][Full Text] [Related]
18. The glomerular basement membrane defect in Alport-type hereditary nephritis: absence of cationic antigenic components.
van den Heuvel LP; Savage CO; Wong M; Price RG; Noel L; Grunfeld JP; Lockwood CM
Nephrol Dial Transplant; 1989; 4(9):770-5. PubMed ID: 2483255
[TBL] [Abstract][Full Text] [Related]
19. The Goodpasture antigen.
Wieslander J
Contrib Nephrol; 1990; 80():56-67. PubMed ID: 1704301
[No Abstract] [Full Text] [Related]
20. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
Hellmark T; Segelmark M; Unger C; Burkhardt H; Saus J; Wieslander J
Kidney Int; 1999 Mar; 55(3):936-44. PubMed ID: 10027930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
